Meritain Health policies
Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
8 policies name J2323, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0751-Natalizumab | 0751 · Commercial | 26 | Original policy ↗ |
| 0285-Plasmapheresis/Plasma Exchange/Therapeutic Apheresis | 0285 · Commercial | 37 | Original policy ↗ |
| 0732-Guillain-Barre Syndrome Treatments | 0732 · Commercial | 43 | Original policy ↗ |
| Rituximab | 0314 · Commercial | 74 | Original policy ↗ |
| Multiple Sclerosis | 0264 · Commercial | 126 | Original policy ↗ |
| Polymerase Chain Reaction Testing: Selected Indications | 0650 · Commercial | 182 | Original policy ↗ |
| Participating provider precertification list for Aetna® | 1013000-01-35 · Effective Nov 1, 2025 · Commercial | 1,389 | Original policy ↗ |
| Participating provider precertification list for Aetna® | Effective Jan 1, 2026 · Commercial | 1,440 | Original policy ↗ |